Combination hypotensive therapy with atenolol, bendrofluazide and hydrallazine.
D000804:Angiotensin II / Q000097:blood; D001262:Atenolol / Q000627:therapeutic use*; D001539:Bendroflumethiazide / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D011412:Propanolamines / Q000627:therapeutic use*; D012083:Renin / Q000097:blood
D011412:Propanolamines; D000804:Angiotensin II; D006830:Hydralazine; D001262:Atenolol; D001539:Bendroflumethiazide; D012083:Renin